Biopharmaceuticals: WuXi Biologics now manages 817 projects

Growth driven by customer confidence

WuXi Biologics, a company present in the Vintage Altaroc Odyssey 2021, applies two key strategies: "Follow the Molecule", which consists of accompanying a drug throughout its development, and "Win the Molecule", which aims to win advanced and commercial projects. Thanks to these approaches, the company is growing rapidly, with over 50% of its new projects coming from the USA.

In 2024, the company also strengthened its manufacturing capabilities, notably with the use of single-use bioreactors, which improve drug production and reduce costs.

Reinforced global manufacturing

WuXi Biologics is expanding its production network in Europe and the United States. Its new site in Worcester, USA, is designed as a factory of the future, with state-of-the-art automated equipment. With its extensive production capacity and 99% batch success rate, the company is establishing itself as a key player in the sector.

A strong commitment to the environment

WuXi Biologics is also committed to sustainability. The company has received several awards for its environmental efforts and has been recognized by the United Nations for its solutions reducing the carbon footprint of biopharmaceutical players by 80%.

With solid growth and a strategy focused on innovation and ecology, WuXi Biologics continues to expand and strengthen its role in the biologics industry.